BioCentury | Aug 1, 2020
Emerging Company Profile

VIB spinout ExeVir targeting COVID-19 with single-domain antibody technology

...by Fund+, will pursue therapies for COVID-19. Ablynx N.V. was the first company formed by Flanders Institute for Biotechnology (VIB)...
...for Biotechnology and Ghent University (VIB-UGent) Disease focus: Infectious Clinical status: Preclinical Founded: 2020 by Flanders Institute for Biotechnology (VIB)...
...Mummenbrauer Patents: None Targets vWF - von Willebrand factor Danielle Golovin, Staff Writer Cablivi, anti-vWF Nanobody, caplacizumab (ALX-0081/ALX-0681) Flanders Institute for Biotechnology (VIB) UCB...
BioCentury | Mar 16, 2020
Product Development

COVID-19 Roundup: Trial starts for Moderna, Sanofi-Regeneron and BioNTech; plus Thermo Fisher, Roche and VIB

...at https://www.biocentury.com/coronavirus . BioCentury Staff BioNTech AG Moderna Inc. Sanofi Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Shanghai Fosun Pharmaceutical Group Co. Ltd. Flanders Institute for Biotechnology (VIB) mRNA-1273 BNT162 COVID-19 cov19count cov19count...
BioCentury | Feb 22, 2020
Product Development

COVID-19 mAb menagerie

...and Development Authority (BARDA) to include therapies to treat COVID-19. A Belgian team led by Flanders Institute for Biotechnology (VIB)...
...Associate Editor Vir Biotechnology Inc. AbCellera Biologics Inc. National Institutes of Health Regeneron Pharmaceuticals Inc. BARDA Ghent University WuXi Biologics Inc. Ligand Pharmaceuticals Inc. Flanders Institute for Biotechnology (VIB) COVID19 coronavirus cov19sci cov19count cov19count cov19sci...
BioCentury | Feb 21, 2020
Emerging Company Profile

Montis: Exploring an untouched macrophage subset in immuno-oncology

...seeded by oncology-focused Droia Ventures in as many weeks. Droia, which teamed up with the Flanders Institute for Biotechnology (VIB)...
BioCentury | Feb 8, 2020
Product Development

Feb. 7 Product Development Quick Takes: Myriad tumbles on revenue miss; plus Verana, Sanofi, VIB, Coda, Blueprint

...by FactSet. Targets ACE2 - Angiotensin-converting enzyme 2 (ACE2) BTK - Bruton’s tyrosine kinase BioCentury Staff PRN2246, SAR442168 Flanders Institute for Biotechnology (VIB) Ghent...
BioCentury | Aug 23, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2019

...Galectin-10 (LGALS10; CLC) Antibodies against LGALS10 could help treat asthma and other allergic airway diseases Flanders Institute for Biotechnology (VIB)...
BioCentury | Jul 11, 2019
Distillery Therapeutics

Treating asthma, allergic diseases with mAbs against crystallized proteins

...E. et al. Science ; published online May 23, 2019 doi:10.1126/science.aaw4295 CONTACT: Savvas N. Savvides, Flanders Institute for Biotechnology (VIB)...
BioCentury | Jun 11, 2019
Distillery Therapeutics

PSEN1 inhibition could treat T cell ALL

...Flanders Institute for Biotechnology (VIB), Leuven, Belgium email: jan.cools@kuleuven.vib.be CONTACT: Bart de Strooper, same affiliation as above email: bart.destrooper@kuleuven.vib.be Claire Quang Flanders Institute for Biotechnology (VIB) KU...
BioCentury | May 7, 2019
Finance

Confo’s €30M growth plan

...at least two more compounds for orphan diseases. Since Confo Therapeutics N.V. spun out of Flanders Institute for Biotechnology (VIB)...
BioCentury | Jan 15, 2019
Distillery Techniques

Chemistry

...Science ; published online Jan. 10, 2019 doi:10.1126/science.aao4827 CONTACT: Bart De Strooper, KU Leuven and Flanders Institute for Biotechnology (VIB)...
Items per page:
1 - 10 of 55
BioCentury | Aug 1, 2020
Emerging Company Profile

VIB spinout ExeVir targeting COVID-19 with single-domain antibody technology

...by Fund+, will pursue therapies for COVID-19. Ablynx N.V. was the first company formed by Flanders Institute for Biotechnology (VIB)...
...for Biotechnology and Ghent University (VIB-UGent) Disease focus: Infectious Clinical status: Preclinical Founded: 2020 by Flanders Institute for Biotechnology (VIB)...
...Mummenbrauer Patents: None Targets vWF - von Willebrand factor Danielle Golovin, Staff Writer Cablivi, anti-vWF Nanobody, caplacizumab (ALX-0081/ALX-0681) Flanders Institute for Biotechnology (VIB) UCB...
BioCentury | Mar 16, 2020
Product Development

COVID-19 Roundup: Trial starts for Moderna, Sanofi-Regeneron and BioNTech; plus Thermo Fisher, Roche and VIB

...at https://www.biocentury.com/coronavirus . BioCentury Staff BioNTech AG Moderna Inc. Sanofi Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Shanghai Fosun Pharmaceutical Group Co. Ltd. Flanders Institute for Biotechnology (VIB) mRNA-1273 BNT162 COVID-19 cov19count cov19count...
BioCentury | Feb 22, 2020
Product Development

COVID-19 mAb menagerie

...and Development Authority (BARDA) to include therapies to treat COVID-19. A Belgian team led by Flanders Institute for Biotechnology (VIB)...
...Associate Editor Vir Biotechnology Inc. AbCellera Biologics Inc. National Institutes of Health Regeneron Pharmaceuticals Inc. BARDA Ghent University WuXi Biologics Inc. Ligand Pharmaceuticals Inc. Flanders Institute for Biotechnology (VIB) COVID19 coronavirus cov19sci cov19count cov19count cov19sci...
BioCentury | Feb 21, 2020
Emerging Company Profile

Montis: Exploring an untouched macrophage subset in immuno-oncology

...seeded by oncology-focused Droia Ventures in as many weeks. Droia, which teamed up with the Flanders Institute for Biotechnology (VIB)...
BioCentury | Feb 8, 2020
Product Development

Feb. 7 Product Development Quick Takes: Myriad tumbles on revenue miss; plus Verana, Sanofi, VIB, Coda, Blueprint

...by FactSet. Targets ACE2 - Angiotensin-converting enzyme 2 (ACE2) BTK - Bruton’s tyrosine kinase BioCentury Staff PRN2246, SAR442168 Flanders Institute for Biotechnology (VIB) Ghent...
BioCentury | Aug 23, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2019

...Galectin-10 (LGALS10; CLC) Antibodies against LGALS10 could help treat asthma and other allergic airway diseases Flanders Institute for Biotechnology (VIB)...
BioCentury | Jul 11, 2019
Distillery Therapeutics

Treating asthma, allergic diseases with mAbs against crystallized proteins

...E. et al. Science ; published online May 23, 2019 doi:10.1126/science.aaw4295 CONTACT: Savvas N. Savvides, Flanders Institute for Biotechnology (VIB)...
BioCentury | Jun 11, 2019
Distillery Therapeutics

PSEN1 inhibition could treat T cell ALL

...Flanders Institute for Biotechnology (VIB), Leuven, Belgium email: jan.cools@kuleuven.vib.be CONTACT: Bart de Strooper, same affiliation as above email: bart.destrooper@kuleuven.vib.be Claire Quang Flanders Institute for Biotechnology (VIB) KU...
BioCentury | May 7, 2019
Finance

Confo’s €30M growth plan

...at least two more compounds for orphan diseases. Since Confo Therapeutics N.V. spun out of Flanders Institute for Biotechnology (VIB)...
BioCentury | Jan 15, 2019
Distillery Techniques

Chemistry

...Science ; published online Jan. 10, 2019 doi:10.1126/science.aao4827 CONTACT: Bart De Strooper, KU Leuven and Flanders Institute for Biotechnology (VIB)...
Items per page:
1 - 10 of 55